Patent · US Active

Method for producing pancreatin pellets

US8691282B2 · kind B2 · utility

1Cited by

5References

12Claims

0Family size

Assignee

Nordmark Arzneimittel GmbH & Co. KG · DE

Inventors

Thomas Moest · Moorrege, DE
Walter Doleschal · Uetersen, DE
Manfred Kurfürst · Moorrege, DE

Key dates

Filing date	Feb 8, 2012
Grant date	Apr 8, 2014
Priority date	—
Expiry date	Feb 8, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In order to avoid compromising the pharmacological effect of pancreatin caused by the addition of auxiliary materials or binding agents, a pancreatin pellet having a 100% pancreatin content consists exclusively of pancreatin with a residual moisture content of less than 3% by weight, preferably less than 1% by weight or less than 0.5% by weight.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.